Clinical trial
Treatment of Refractory (Acute or Chronic) Graft-Versus-Host Disease by the…
NCT00447460 · University of Salamanca, Other · Unknown status
Key facts
| NCT number | NCT00447460 |
|---|---|
| Title | Treatment of Refractory (Acute or Chronic) Graft-Versus-Host Disease by the Infusion of Expanded in-Vitro Allogenic Mesenchymal Stem Cell |
| Official title | A Phase I/II Trial in Treating Patients With Graft-Versus-Host Disease by the Infusion of Expanded in-Vitro Allogenic Mesenchymal Stem Cell |
| Lead sponsor | University of Salamanca, Other |
| Collaborators | Haematology Service,University Hospital of Salamanca, MªConsuelo del Cañizo Fernández-Roldán |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Graft-vs-Host Disease (GVHD) |
| Intervention type | Procedure |
| Interventions | Mesenchymal stem cell (MSC) |
| Enrollment | 15 |
| Start date | Jan 1, 2007 |
| Completion | Aug 1, 2009 |
| First posted | Mar 14, 2007 |
| Last update posted | Mar 22, 2007 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: